Glucose deprivation activates a metabolic and signaling amplification loop leading to cell death

[1]  Vito Pistoia,et al.  Fasting Cycles Retard Growth of Tumors and Sensitize a Range of Cancer Cell Types to Chemotherapy , 2012, Science Translational Medicine.

[2]  T. Golub,et al.  Selective killing of cancer cells with a small molecule targeting stress response to ROS , 2011, Nature.

[3]  A. Subramanian,et al.  Selective killing of K-ras mutant cancer cells by small molecule inducers of oxidative stress , 2011, Proceedings of the National Academy of Sciences.

[4]  Matteo Pellegrini,et al.  Global Phosphoproteomics Reveals Crosstalk Between Bcr-Abl and Negative Feedback Mechanisms Controlling Src Signaling , 2011, Science Signaling.

[5]  D. Hanahan,et al.  Hallmarks of Cancer: The Next Generation , 2011, Cell.

[6]  S. Nelson,et al.  Melanomas acquire resistance to B-RAF(V600E) inhibition by RTK or N-RAS upregulation , 2010, Nature.

[7]  H. Coller,et al.  The hexosamine biosynthetic pathway couples growth factor-induced glutamine uptake to glucose metabolism. , 2010, Genes & development.

[8]  F. Miot,et al.  The Nonphagocytic NADPH Oxidase Duox1 Mediates a Positive Feedback Loop During T Cell Receptor Signaling , 2010, Science Signaling.

[9]  T. Graeber,et al.  Activation of aortic endothelial cells by oxidized phospholipids: a phosphoproteomic analysis. , 2010, Journal of proteome research.

[10]  Sang Gyun Kim,et al.  Glucose addiction of TSC null cells is caused by failed mTORC1-dependent balancing of metabolic demand with supply. , 2010, Molecular cell.

[11]  A. Munnich,et al.  Calcium signalling-dependent mitochondrial dysfunction and bioenergetics regulation in respiratory chain Complex II deficiency , 2010, Cell Death and Differentiation.

[12]  Paul S Mischel,et al.  Differential sensitivity of melanoma cell lines with BRAFV600E mutation to the specific Raf inhibitor PLX4032 , 2010, Journal of Translational Medicine.

[13]  Jing Chen,et al.  Tyrosine Phosphorylation Inhibits PKM2 to Promote the Warburg Effect and Tumor Growth , 2009, Science Signaling.

[14]  R. Deberardinis,et al.  Glioblastoma cells require glutamate dehydrogenase to survive impairments of glucose metabolism or Akt signaling. , 2009, Cancer research.

[15]  K. Kinzler,et al.  Glucose Deprivation Contributes to the Development of KRAS Pathway Mutations in Tumor Cells , 2009, Science.

[16]  Diana Anderson,et al.  Tks5-Dependent, Nox-Mediated Generation of Reactive Oxygen Species Is Necessary for Invadopodia Formation , 2009, Science Signaling.

[17]  D. Spitz,et al.  Glucose deprivation-induced metabolic oxidative stress and cancer therapy. , 2009, Journal of cancer research and therapeutics.

[18]  Hanna Y. Irie,et al.  Antioxidant and oncogene rescue of metabolic defects caused by loss of matrix attachment , 2009, Nature.

[19]  Paul S Mischel,et al.  The AMPK agonist AICAR inhibits the growth of EGFRvIII-expressing glioblastomas by inhibiting lipogenesis , 2009, Proceedings of the National Academy of Sciences.

[20]  D. Spitz,et al.  Mitochondrial electron transport chain blockers enhance 2-deoxy-D-glucose induced oxidative stress and cell killing in human colon carcinoma cells , 2009, Cancer biology & therapy.

[21]  David M. Sabatini,et al.  Tumours with PI3K activation are resistant to dietary restriction , 2009, Nature.

[22]  L. Oberley,et al.  Increased levels of superoxide and H2O2 mediate the differential susceptibility of cancer cells versus normal cells to glucose deprivation. , 2009, The Biochemical journal.

[23]  K. Hashiguchi,et al.  Establishment of human cell lines lacking mitochondrial DNA. , 2009, Methods in molecular biology.

[24]  Shenmin Zhang,et al.  A modified cysteinyl-labeling assay reveals reversible oxidation of protein tyrosine phosphatases in angiomyolipoma cells , 2008, Proceedings of the National Academy of Sciences.

[25]  M. Yuneva.  Finding an “Achilles’ heel” of cancer: The role of glucose and glutamine metabolism in the survival of transformed cells , 2008, Cell cycle.

[26]  K. Khoo,et al.  Redox regulation of the protein tyrosine phosphatase PTP1B in cancer cells , 2008, The FEBS journal.

[27]  R. Deberardinis,et al.  The biology of cancer: metabolic reprogramming fuels cell growth and proliferation. , 2008, Cell metabolism.

[28]  Nicola Zamboni,et al.  Deficiency in glutamine but not glucose induces MYC-dependent apoptosis in human cells , 2007, The Journal of cell biology.

[29]  Hong Wu,et al.  Identification of the JNK signaling pathway as a functional target of the tumor suppressor PTEN. , 2007, Cancer cell.

[30]  C. Dang,et al.  Effects of hypoxia on tumor metabolism , 2007, Cancer and Metastasis Reviews.

[31]  T. Graeber,et al.  Phosphorylation of the ATP-binding loop directs oncogenicity of drug-resistant BCR-ABL mutants , 2006, Proceedings of the National Academy of Sciences.

[32]  Steven P Gygi,et al.  A probability-based approach for high-throughput protein phosphorylation analysis and site localization , 2006, Nature Biotechnology.

[33]  Jinsong Liu,et al.  Selective killing of oncogenically transformed cells through a ROS-mediated mechanism by beta-phenylethyl isothiocyanate. , 2006, Cancer cell.

[34]  M. Ushio-Fukai.  Localizing NADPH Oxidase–Derived ROS , 2006, Science's STKE.

[35]  T. Cloughesy,et al.  Mammalian target of rapamycin inhibition promotes response to epidermal growth factor receptor kinase inhibitors in PTEN-deficient and PTEN-intact glioblastoma cells. , 2006, Cancer research.

[36]  Benno Schwikowski,et al.  Signal Maps for Mass Spectrometry-based Comparative Proteomics* , 2006, Molecular & Cellular Proteomics.

[37]  F. Domann,et al.  Inhibition of glutamate cysteine ligase activity sensitizes human breast cancer cells to the toxicity of 2-deoxy-D-glucose. , 2006, Cancer research.

[38]  G. Sarosi,et al.  Subcellular targeting of oxidants during endothelial cell migration , 2005, The Journal of cell biology.

[39]  T. Kawahara,et al.  Point Mutations in the Proline-rich Region of p22phox Are Dominant Inhibitors of Nox1- and Nox2-dependent Reactive Oxygen Generation* , 2005, Journal of Biological Chemistry.

[40]  R. Deberardinis,et al.  The glucose dependence of Akt-transformed cells can be reversed by pharmacologic activation of fatty acid β-oxidation , 2005, Oncogene.

[41]  Michael Karin,et al.  Reactive Oxygen Species Promote TNFα-Induced Death and Sustained JNK Activation by Inhibiting MAP Kinase Phosphatases , 2005, Cell.

[42]  S. Flanagan,et al.  Mitochondrial O2*- and H2O2 mediate glucose deprivation-induced stress in human cancer cells. , 2005, The Journal of biological chemistry.

[43]  Kap-Seok Yang,et al.  Reversible oxidation and inactivation of the tumor suppressor PTEN in cells stimulated with peptide growth factors. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[44]  A. Alavi,et al.  Akt Stimulates Aerobic Glycolysis in Cancer Cells , 2004, Cancer Research.

[45]  Michael P. Myers,et al.  Redox regulation of protein tyrosine phosphatase 1B involves a sulphenyl-amide intermediate , 2003, Nature.

[46]  Toshiyuki Fukada,et al.  Reversible oxidation and inactivation of protein tyrosine phosphatases in vivo. , 2002, Molecular cell.

[47]  Michael E Phelps,et al.  Positron emission tomography scanning: current and future applications. , 2002, Annual review of medicine.

[48]  L. Zhu,et al.  Insulin-stimulated Hydrogen Peroxide Reversibly Inhibits Protein-tyrosine Phosphatase 1B in Vivo and Enhances the Early Insulin Action Cascade* , 2001, The Journal of Biological Chemistry.

[49]  T. Galeotti,et al.  A Redox Signaling Mechanism for Density-dependent Inhibition of Cell Growth* , 2000, The Journal of Biological Chemistry.

[50]  R. Mamillapalli,et al.  Genetic deletion of the Pten tumor suppressor gene promotes cell motility by activation of Rac1 and Cdc42 GTPases , 2000, Current Biology.

[51]  H. Forman,et al.  Dominant-negative Jun N-terminal protein kinase (JNK-1) inhibits metabolic oxidative stress during glucose deprivation in a human breast carcinoma cell line. , 2000, Free radical biology & medicine.

[52]  L. Ridnour,et al.  Glucose Deprivation‐Induced Oxidative Stress in Human Tumor Cells: A Fundamental Defect in Metabolism? , 2000, Annals of the New York Academy of Sciences.

[53]  Y. Lee,et al.  Metabolic oxidative stress activates signal transduction and gene expression during glucose deprivation in human tumor cells. , 1999, Free radical biology & medicine.

[54]  D. Botstein,et al.  Cluster analysis and display of genome-wide expression patterns. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[55]  S. Rhee,et al.  Reversible Inactivation of Protein-tyrosine Phosphatase 1B in A431 Cells Stimulated with Epidermal Growth Factor* , 1998, The Journal of Biological Chemistry.

[56]  D. Spitz,et al.  Glucose Deprivation-induced Cytotoxicity and Alterations in Mitogen-activated Protein Kinase Activation Are Mediated by Oxidative Stress in Multidrug-resistant Human Breast Carcinoma Cells* , 1998, The Journal of Biological Chemistry.

[57]  M. Wigler,et al.  P-TEN, the tumor suppressor from human chromosome 10q23, is a dual-specificity phosphatase. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[58]  David E. Housman,et al.  Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumours , 1996, Nature.

[59]  J. Yodoi,et al.  Persistent oxidative stress in cancer , 1995, FEBS letters.

[60]  C. Nathan,et al.  Production of large amounts of hydrogen peroxide by human tumor cells. , 1991, Cancer research.

[61]  C. White,et al.  Superoxide dismutase and catalase conjugated to polyethylene glycol increases endothelial enzyme activity and oxidant resistance. , 1988, The Journal of biological chemistry.

[62]  T. Chou,et al.  Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors. , 1984, Advances in enzyme regulation.

[63]  S. Weinhouse.  On respiratory impairment in cancer cells. , 1956, Science.